Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.5037
-0.0298-5.59%
Post-market: 0.52000.0163+3.24%18:43 EDT
Volume:641.63K
Turnover:334.34K
Market Cap:72.54M
PE:-1.06
High:0.5329
Open:0.5300
Low:0.5037
Close:0.5335
52wk High:10.62
52wk Low:0.2950
Shares:144.01M
Float Shares:120.21M
Volume Ratio:0.66
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4752
EPS(LYR):-0.7570
ROE:-150.82%
ROA:-84.32%
PB:4.16
PE(LYR):-0.67

Loading ...

Applied Therapeutics (APLT) Receives a Hold from RBC Capital

TIPRANKS
·
Aug 14

Applied Therapeutics Inc. Considers Reverse Stock Split to Regain Nasdaq Compliance

Reuters
·
Aug 14

William Blair Sticks to Its Hold Rating for Applied Therapeutics (APLT)

TIPRANKS
·
Aug 14

Applied Therapeutics Q2 EPS USD -0.15

THOMSON REUTERS
·
Aug 14

BRIEF-Applied Therapeutics Says Unaudited Estimate Of Total Stockholders’ Equity As Of June 30 Is About $17.4 Mln

Reuters
·
Aug 12

Applied Therapeutics Inc - Prelim Unaudited Estimate of Total Stockholders’ Equity as of June 30, 2025 Is About$17.4 Million - SEC Filing

THOMSON REUTERS
·
Aug 12

Applied Therapeutics Inc. Faces Potential Delisting from Nasdaq; Awaits Decision on Transfer to Nasdaq Capital Market

Reuters
·
Aug 12

Applied Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
Aug 01

BRIEF-Applied Therapeutics announces key leadership appointments

Reuters
·
Jun 18

Applied Therapeutics Announces New Leadership Appointments: Evan Bailey as Chief Medical Officer and Dottie Caplan as Executive Vice President

Reuters
·
Jun 18

Applied Therapeutics Inc. Concluded Annual Stockholders Meeting

Reuters
·
Jun 12

Applied announces INSPIRE Phase 2/3 trial primary endpoint not significant

TIPRANKS
·
May 18

Applied Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

RBC Capital Keeps Their Hold Rating on Applied Therapeutics (APLT)

TIPRANKS
·
May 14

BRIEF-Applied Therapeutics Q1 Operating Income USD -25.525 Million

Reuters
·
May 14

Applied Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 05

William Blair Sticks to Its Hold Rating for Applied Therapeutics (APLT)

TIPRANKS
·
Apr 15

Press Release: Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Dow Jones
·
Apr 15

North American Morning Briefing: China Raises Tariffs on U.S. in Latest Salvo

Dow Jones
·
Apr 11

Applied Therapeutics files Form 12b-25 with SEC

TIPRANKS
·
Mar 31